Seilern Investment Management Ltd Reduces Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Seilern Investment Management cut its UnitedHealth stake by 43.1% in the second quarter, selling 121,096 shares and retaining 160,023 shares worth approximately $66.5 million. UnitedHealth remains the firm's second-largest holding at 8.4% of its portfolio.
• UnitedHealth reported quarterly EPS of $6.38, beating estimates of $4.94, while revenue reached $112.03 billion. The company maintained 2026 EPS guidance of $19.50–$20.00 and increased its quarterly dividend to $2.32 per share.
• Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and a $455.92 price target, although the CEO’s sale of 500 shares and the stock’s premium valuation provide modest counterpoints.

Seilern Investment Management Ltd trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 43.1% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 160,023 shares of the healthcare conglomerate's stock after selling 121,096 shares during the period. UnitedHealth Group comprises approximately 8.4% of Seilern Investment Management Ltd's investment portfolio, making the stock its 2nd biggest position. Seilern Investment Management Ltd's holdings in UnitedHealth Group were worth $66,510,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Worth Asset Management LLC boosted its stake in UnitedHealth Group by 22.1% in the 2nd quarter. Worth Asset Management LLC now owns 1,525 shares of the healthcare conglomerate's stock worth $634,000 after purchasing an additional 276 shares during the period. Beaird Harris Wealth Management LLC grew its position in UnitedHealth Group by 50.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 204 shares of the healthcare conglomerate's stock worth $85,000 after acquiring an additional 68 shares in the last quarter. Rockland Trust Co. raised its holdings in UnitedHealth Group by 1.1% during the second quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate's stock valued at $1,076,000 after buying an additional 29 shares in the last quarter. Quantum Financial Advisors LLC raised its stake in shares of UnitedHealth Group by 6.0% in the 2nd quarter. Quantum Financial Advisors LLC now owns 1,138 shares of the healthcare conglomerate's stock valued at $473,000 after acquiring an additional 64 shares in the last quarter. Finally, Williams & Novak LLC raised its position in shares of UnitedHealth Group by 4.7% in the second quarter. Williams & Novak LLC now owns 776 shares of the healthcare conglomerate's stock valued at $323,000 after purchasing an additional 35 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 500 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total value of $205,000.00. Following the transaction, the chief executive officer directly owned 16,497 shares of the company's stock, valued at $6,763,770. This trade represents a 2.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $406.54 on Friday. UnitedHealth Group Incorporated has a 1-year low of $244.37 and a 1-year high of $461.62. The stock has a market cap of $369.20 billion, a P/E ratio of 26.16, a PEG ratio of 1.41 and a beta of 0.62. The stock has a 50 day simple moving average of $414.09 and a 200 day simple moving average of $350.83. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. The business had revenue of $112.03 billion during the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm's revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were issued a dividend of $2.32 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.21. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's payout ratio is currently 59.72%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth was highlighted as a leading long-term value stock by Zacks, supporting the view that its scale, diversified healthcare operations and earnings potential could appeal to long-term investors. Why UnitedHealth Group Is a Top Value Stock for the Long-Term
• Positive Sentiment: UNH was included among healthcare stocks benefiting from strengthening defensive demand and improving earnings expectations. The company’s recent quarterly results also exceeded consensus estimates, with earnings of $6.38 per share versus expectations of $4.94, while maintaining 2026 earnings guidance of $19.50 to $20.00 per share. 4 Healthcare Stocks to Watch as Defensive Demand Strengthens
• Positive Sentiment: A separate report said UnitedHealth is regaining investor favor after a volatile period, suggesting improving sentiment around the company’s outlook and recovery potential. Why UnitedHealth Group Is Regaining Favor After a Volatile Stretch
• Neutral Sentiment: UnitedHealth was described as the leader of its health-insurance peer group, but investors are paying a premium for that perceived quality. The valuation could remain justified if the company sustains superior execution, though it may limit further upside if growth slows. UNH Leads Its Peer Group. You Pay For That
• Negative Sentiment: CEO Patrick Hugh Conway sold 500 UNH shares for approximately $205,000, reducing his direct holdings by 2.94%. The sale is relatively small compared with his remaining stake, but insider selling can create a modest sentiment headwind. SEC Insider Transaction Filing

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on UNH shares. Morgan Stanley boosted their price target on UnitedHealth Group from $468.00 to $529.00 and gave the company an "overweight" rating in a research note on Friday, July 17th. UBS Group lifted their target price on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a "buy" rating in a research note on Friday, July 17th. Weiss Ratings cut shares of UnitedHealth Group from a "hold (c)" rating to a "hold (c-)" rating in a research report on Tuesday, July 28th. Argus raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 price target for the company in a research note on Wednesday, April 22nd. Finally, Erste Group Bank raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Monday, April 27th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $455.92.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source